Top companies on the NasdaqCM by Price to Sales Ratio (P/S)

This ranking features the top 603 companies on the NasdaqCM ranked by Price to Sales Ratio (P/S), averaging a Price to Sales Ratio (P/S) of 306,337.03, for January 15, 2025.

NasdaqCM

All sectors

#	Name	Price to Sales Ratio (P/S)	Reported Date	Stock Price	Change	Country
1	Inhibikase Therapeutics, Inc. 1 IKT	184,503,984.00	Jan. 14, 2025	USD 2.66	NA	United States
2	Benitec Biopharma Inc. 2 BNTC	40,164.37	Jan. 14, 2025	USD 10.38	-0.10%	United States
3	Greenwich LifeSciences, Inc. 3 GLSI	29,258.97	Jan. 14, 2025	USD 12.06	-1.63%	United States
4	DatChat, Inc. 4 DATS	28,515.59	Jan. 14, 2025	USD 4.88	-9.96%	United States
5	Forte Biosciences, Inc. 5 FBRX	15,578.39	Jan. 14, 2025	USD 14.62	-8.62%	United States
6	Immix Biopharma, Inc. 6 IMMX	11,499.83	Jan. 14, 2025	USD 2.00	-5.66%	United States
7	Bullfrog AI Holdings, Inc. Common Stock 7 BFRG	10,613.47	Jan. 14, 2025	USD 2.10	-0.47%	United States
8	Cadrenal Therapeutics, Inc. Common Stock 8 CVKD	10,296.97	Jan. 14, 2025	USD 15.99	NA	United States
9	Viking Therapeutics, Inc. 9 VKTX	8,672.07	Jan. 14, 2025	USD 33.93	-12.73%	United States
10	NRx Pharmaceuticals, Inc. 10 NRXP	7,709.99	Jan. 14, 2025	USD 5.10	3.87%	United States
11	Rezolute, Inc. 11 RZLT	4,715.37	Jan. 14, 2025	USD 4.72	-0.63%	United States
12	Viridian Therapeutics, Inc. 12 VRDN	4,422.27	Jan. 14, 2025	USD 16.86	-5.12%	United States
13	Gaxos.ai Inc. 13 GXAI	3,974.19	Jan. 14, 2025	USD 1.71	2.40%	United States
14	Context Therapeutics Inc. 14 CNTX	3,918.10	Jan. 14, 2025	USD 0.99	-3.87%	United States
15	Tenax Therapeutics, Inc. 15 TENX	3,785.72	Jan. 14, 2025	USD 6.43	4.38%	United States
16	Checkpoint Therapeutics, Inc. 16 CKPT	3,293.60	Jan. 14, 2025	USD 3.17	-0.94%	United States
17	INmune Bio, Inc. 17 INMB	3,143.74	Jan. 14, 2025	USD 5.96	-8.87%	United States
18	Quantum Computing, Inc. 18 QUBT	2,480.95	Jan. 14, 2025	USD 7.43	13.96%	United States
19	NextDecade Corporation 19 NEXT	2,302.57	Jan. 14, 2025	USD 8.05	3.34%	United States
20	Lightwave Logic, Inc. 20 LWLG	2,108.20	Jan. 14, 2025	USD 1.95	2.63%	United States
21	Celcuity Inc. 21 CELC	1,702.50	Jan. 14, 2025	USD 10.53	-2.95%	United States
22	Renovaro Biosciences Inc. 22 RENB	713.84	Jan. 14, 2025	USD 0.82	-9.33%	United States
23	Aldeyra Therapeutics, Inc. 23 ALDX	712.86	Jan. 14, 2025	USD 4.70	-1.47%	United States
24	Cardio Diagnostics Holdings, Inc. 24 CDIO	646.57	Jan. 14, 2025	USD 0.57	-9.14%	United States
25	Aqua Metals, Inc. 25 AQMS	612.15	Jan. 14, 2025	USD 2.06	-0.96%	United States
26	Pulse Biosciences, Inc. 26 PLSE	608.10	Jan. 14, 2025	USD 17.20	-4.55%	United States
27	BioSig Technologies, Inc. 27 BSGM	570.08	Jan. 14, 2025	USD 1.29	-8.51%	United States
28	Soleno Therapeutics, Inc. 28 SLNO	532.27	Jan. 14, 2025	USD 42.54	-1.21%	United States
29	Serve Robotics Inc. 29 SERV	503.24	Jan. 14, 2025	USD 16.41	11.03%	United States
30	Alaunos Therapeutics, Inc. 30 TCRT	483.04	Jan. 14, 2025	USD 1.81	4.02%	United States
31	Synaptogenix, Inc. 31 SNPX	465.65	Jan. 14, 2025	USD 3.53	5.69%	United States
32	Kala Pharmaceuticals, Inc. 32 KALA	451.31	Jan. 14, 2025	USD 6.65	1.53%	United States
33	U.S. Gold Corp. 33 USAU	449.67	Jan. 14, 2025	USD 6.36	0.95%	United States
34	Anixa Biosciences, Inc. 34 ANIX	439.61	Jan. 14, 2025	USD 2.13	-2.74%	United States
35	Ideal Power Inc. 35 IPWR	411.10	Jan. 14, 2025	USD 7.17	-2.32%	United States
36	Atomera Incorporated 36 ATOM	404.28	Jan. 14, 2025	USD 9.30	-11.85%	United States
37	ProKidney Corp. 37 PROK	403.16	Jan. 14, 2025	USD 1.58	-4.24%	United States
38	Eledon Pharmaceuticals, Inc. 38 ELDN	395.77	Jan. 14, 2025	USD 3.71	-4.63%	United States
39	Creative Medical Technology Holdings, Inc. 39 CELZ	341.62	Jan. 14, 2025	USD 2.15	-3.59%	United States
40	Aileron Therapeutics, Inc. 40 ALRN	341.16	Jan. 10, 2025	USD 2.11	9.33%	United States
41	NextNav Inc. 41 NN	332.29	Jan. 14, 2025	USD 12.63	-4.32%	United States
42	Inovio Pharmaceuticals, Inc. 42 INO	331.87	Jan. 14, 2025	USD 1.87	-1.58%	United States
43	Cardiff Oncology, Inc. 43 CRDF	317.66	Jan. 14, 2025	USD 3.29	-5.19%	United States
44	American Battery Technology Company Common Stock 44 ABAT	284.51	Jan. 14, 2025	USD 1.82	-1.62%	United States
45	Regulus Therapeutics Inc. 45 RGLS	265.69	Jan. 14, 2025	USD 1.23	-5.38%	United States
46	ZyVersa Therapeutics, Inc. 46 ZVSA	239.56	Jan. 14, 2025	USD 1.49	12.03%	United States
47	Monogram Orthopaedics, Inc. 47 MGRM	232.20	Jan. 14, 2025	USD 2.47	0.82%	United States
48	Nexalin Technology, Inc. 48 NXL	228.18	Jan. 14, 2025	USD 2.78	10.76%	United States
49	Akso Health Group 49 AHG	226.44	Jan. 14, 2025	USD 1.38	6.15%	China
50	Cyclacel Pharmaceuticals, Inc. 50 CYCCP	218.41	Jan. 14, 2025	USD 8.50	13.33%	United States

1 2 3 4 … 13

Frequently Asked Questions

Which company on the NasdaqCM has the highest Price to Sales Ratio (P/S) ?

The company on the NasdaqCM with the highest Price to Sales Ratio (P/S) is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at 184,503,984.00.
Which company on the NasdaqCM has the lowest Price to Sales Ratio (P/S) ?

The company on the NasdaqCM with the lowest Price to Sales Ratio (P/S) is LM Funding America, Inc. (NasdaqCM: LMFA) at 0.00.

What are the top 10 companies on the NasdaqCM by Price to Sales Ratio (P/S) ?

The top 10 companies on the NasdaqCM by Price to Sales Ratio (P/S) are Inhibikase Therapeutics, Inc., Benitec Biopharma Inc., Greenwich LifeSciences, Inc., DatChat, Inc., Forte Biosciences, Inc., Immix Biopharma, Inc., Bullfrog AI Holdings, Inc. Common Stock, Cadrenal Therapeutics, Inc. Common Stock, Viking Therapeutics, Inc. and NRx Pharmaceuticals, Inc..
What are the bottom 10 companies on the NasdaqCM by Price to Sales Ratio (P/S) ?

The bottom 10 companies on the NasdaqCM by Price to Sales Ratio (P/S) are LM Funding America, Inc., Snail, Inc. Class A Common Stock, Streamline Health Solutions, Inc., Ispire Technology Inc., Sound Group Inc., Kopin Corporation, Lipella Pharmaceuticals Inc., SigmaTron International, Inc., LuxUrban Hotels Inc. and Staffing 360 Solutions, Inc..